.jpg){kind=logo}
.jpg)
Dipu Ghosh, MSEE, MBA.
Chief Executive Officer
Mr. Ghosh has 30+ years of product development and business experience in the medical devices and electronics industries. He is a co-founder of and serves as the CEO of Hepatiq, Inc.
Mr. Ghosh invented the algorithms for automating the quantitative liver spleen scan techniques used by the HEPATIQ software. Mr. Ghosh is also President of Syprosoft, Inc., an engineering services firm he founded in 2002.
Previously, Mr. Ghosh has held VP and Director level positions at several leading medical device companies. He has experience with both small and large organizations. He started his career with GE Medical Systems, where he was a key designer for a leading CT scanner.
Mr. Ghosh has an MS in Electrical Engineering from the University of Rochester, and an MBA from Marquette University.
.jpg)
John Hoefs, MD.
Chief Operating Officer
Dr. Hoefs has 30+ years of clinical and research experience with liver disease. He is a co-founder of and serves as the COO of Hepatiq, Inc.
Dr. Hoefs pioneered the development of the quantitative liver spleen scan (QLSS) and has published multiple papers supporting its utility. He is a practicing hepatologist at the Liver Specialty Center and Professor Emeritus at the University of Califonia, Irvine.
Dr. Hoefs has collected data and experience on over 20,000 patients with chronic liver disease. He has published extensively including in Gastroenterology, Hepatology and the New England Journal of Medicine.
Dr. Hoefs has an MD from the George Washington University Medical School.